TipRanks
Nascent Biotech Inc. (NBIO)
OTHER OTC:NBIO
US Market
NBIO
Nascent Biotech
RESEARCH TOOLSreports

Nascent Biotech (NBIO) Income Statement

47 Followers

Nascent Biotech Income Statement

Last quarter (Q1 2025), Nascent Biotech's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Nascent Biotech's net income was $-377.39K. See Nascent Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
$ 0.00$ 0.00$ 1.00M$ 750.00K$ 0.00
Gross Profit
$ -320.00K$ 0.00$ 1.00M$ 750.00K$ 0.00
Operating Expenses
$ 1.91M$ 2.16M$ 1.46M$ 2.15M$ 3.45M
Depreciation and Amortization
$ 2.23M$ 2.16M$ 457.05K$ 1.40M$ 3.45M
EBITDA
$ 527.43K$ -1.07M$ 16.78K$ -602.72K$ -470.00K
Operating Income
$ -2.23M$ -2.16M$ -457.00K$ -1.40M$ -3.45M
Other Income/Expenses
$ 142.20K$ -645.00K$ -13.34K$ 441.60K$ -557.00K
Pretax Income
$ -2.09M$ -2.80M$ -470.00K$ -959.00K$ -4.00M
Net Income
$ -2.09M$ -2.80M$ -470.00K$ -959.00K$ -4.00M
Per Share Metrics
Basic EPS
$ -0.01$ -0.02$ 0.00$ -0.01$ -0.12
Diluted EPS
$ -0.01$ -0.02$ 0.00$ -0.01$ -0.12
Weighted Average Shares Outstanding
 155.74M 118.57M 107.74M 72.34M 34.39M
Weighted Average Shares Outstanding (Diluted)
 155.74M 118.57M 107.74M 72.34M 34.39M
Currency in USD

Nascent Biotech Earnings and Revenue History